🇺🇸 FDA
Patent

US 10314892

Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device

granted A61KA61K31/155A61K38/31

Quick answer

US patent 10314892 (Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device) held by Rani Therapeutics, LLC expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rani Therapeutics, LLC
Grant date
Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/155, A61K38/31, A61K9/0053, A61K9/4808